The aim of the study was to assess the seroprevalence of Coxiella burnetii in cattle herds in different regions of Poland. A total of 1150 serum samples collected from 443 cattle herds from 14 provinces were tested using complement fixation test. The seroprevalence was different in individual regions of Poland. The average percentage of seropositive herds was 40.41% and these herds were identified in each province tested.
Introduction
Q fever (coxiellosis) is an infectious disease of animals and humans, widely distributed throughout the world, with the exception of New Zealand. The causative agent, Coxiella burnetii, is an obligate intracellular bacterium with a complex life cycle (2, 16, 17) . Due to a high zoonotic potential and the fact that outbreaks of Q fever in ruminants occur together with infection in humans, it is reasonable to perform monitoring of animals. Moreover, coxiellosis may cause high economic losses, especially in dairy cattle, due to a decrease in fertility rate and the restrictions on milk trade. In the majority of European countries, eradication programmes have not been implemented and Q fever is only a notifiable disease. Furthermore, limited accessibility to vaccines hinders the eradication of this pathogen. The studies conducted by other research centers in Europe have demonstrated that the prevalence of C. burnetii infection in ruminants, including dairy cattle, has been increasing in recent years. The seroprevalence in Europe was estimated at a range between 38% and 79% (3, 6, 12, 14) . The results of serological and molecular tests (PCRs) confirm the presence of C. burnetii in cattle herds. The biggest worldwide outbreak of Q fever took place between 2007 and 2010 in the Netherlands and it was initially considered as the cause of increasing prevalence in other European countries. Recent phylogenetic analyses have shown that the strains isolated from cows from other European cattle belong to a different cluster than the Dutch one (18) . An increasing number of Q fever cases is probably due to the lack of surveillance and eradication programmes in most of EU Member States. An increase in trade in animals is an additional factor propitious for the spread of the disease. Detailed data about Q fever seroprevalence in Polish ruminants is limited and is mainly related to an endemic region in south-eastern Poland (13) . Therefore, the aim of this study was to assess the seroprevalence of Coxiella burnetii in cattle herds in different regions of Poland. (9) according to the manufacturer's instructions, using reagents supplied by Siemens (Germany). The mixed antigen of C. burnetii (phase I and phase II) was used. The temperature of inactivation of sera was 57 ± 1°C. According to the OIE guidelines, the cut-off titre was 1:10. Any sample with CFT titre <10 was considered negative, while samples with titre ≥10 were considered positive.
Material and Methods

Samples
Results
The results of serological examination by CFT are shown in Table 1 and Fig. 1 . The samples from Dolnośląskie and Opolskie provinces were not available, so the seroprevalence in these regions was not assessed. The data indicated that C. burnetii serologically positive cattle was detected in all provinces under this study. However, it is difficult to evaluate the percentage of positive herds in Małopolskie province because the samples were only taken from one herd. The percentage of seropositive herds ranged from 15.79% in the Warmińsko-Mazurskie province to 84.62% in the Mazowieckie province, with an average of 40.41%. In several provinces (Kujawsko-Pomorskie, Lubuskie, Mazowieckie, Podlaskie, Pomorskie) the seropositive herds were detected in each county tested (Fig. 1) .
Discussion
To our knowledge, the present survey is the first epidemiological report on the seroprevalence of C. burnetii in Polish cattle that covered the whole country. In the available literature there is information about cases of Q fever in cattle, but it is mainly related to the endemic region of the disease. The first case of Q fever in animals in Poland was identified in 1956. The largest epidemic of Q fever among humans and animals was recognised near Zamość (Lubelskie province in eastern Poland) in 1983 (5, 11) . Since that time, C. burnetii antibodies have been found in cattle from this area and from south -eastern Poland (4, 8, 13) . For many years the studies on Q fever prevalence in Poland both in animals and in humans were very limited. Since 2010, Q fever has been included in the serological monitoring programme performed by the Veterinary Inspection. Moreover, the National Veterinary Research Institute has performed a serological survey for Q fever in the frame of the Multiannual Research Programme. The data presented in this article were collected from the last edition of this programme (years [2014] [2015] . The results show a high percentage of seropositive cattle herds in Poland. The average percentage of seropositive herds was 40.41%. The highest seroprevalence was noted in Mazowieckie (84.62%) and Lubelskie (78.57%) provinces. The lowest seropositive herds, below 20%, were in Warmińsko-Mazurskie and Łódzkie provinces. Surprisingly, the seroprevalence below the national average was noted in Podkarpackie province (29.91%), which is part of the endemic area of Q fever. On the other hand, we observed that seroprevalence in this region is widespread and seropositive herds were identified in each county. The lower seoprevalence compared to national average was in Warmińsko-Mazurskie, Wielkopolskie, and Zachodniopomorskie. It is difficult to evaluate the seroprevalence in Malopolskie because only one herd was tested. We did not have the possibility to collect more samples from this area. Generally, the level of seroprevalence in Poland is similar to other European countries. The increasing prevalence of C. burnetii antibodies in milk and serum has been observed in Europe in recent years. For example, the following levels of seroprevalence have been reported: 79% in the Netherlands (12), 38% in Ireland (14) , 67% in Northern Spain (3), 48% in Northern Ireland (10), 79% in Denmark (1), and 71% in Belgium (6) . Moreover, Tilburg et al. (18) showed that 76% commercially available milk samples or milk products from 28 countries contain significant amounts of C. burnetii DNA. These results confirmed high prevalence of C. burnetii among the dairy cattle population worldwide. A national survey of Swedish cattle in 1993 showed low seroprevalence (1.3%), while currently the prevalence of antibodies varied from 55.9% to 64.6% depending on geographic region. It is difficult to compare the current epidemiological situation in Poland with the previous decade due to the lack of data. It should be noted that in several European countries, including Poland, the vaccine against C. burnetii is available. Nevertheless, vaccinated animals were excluded from this study. However, it cannot be ruled out that part of the seropositive animals could have been vaccinated. Initially it was assumed that an increasing number of Q fever cases in cattle was related to the epidemic in the Netherlands, which took place between 2007 and 2010 (15) . The latest phylogenetic results showed that there is no epidemiological link between German isolates and the Dutch outbreak clone. Based on the genotype of C. burnetii in consumer milk products from different countries, Tiburg et al. (18) indicated that the Dutch Q fever outbreak was not related to the presence of C. burnetii in cattle.
The data presented in this study show that C. burnetii is widespread in Poland, and the surveillance has to be continued, especially as Q fever is a zoonotic disease and there is a high risk of transmission to humans. At the current state of knowledge, it is known that ,,sheep and goat" related genotypes are often isolated from humans, but it is impossible to rule out that ,,cattle strains" of C. burnetii are not infectious to humans. Although in the literature there have already been first reports presenting this scientific hypothesis, it still needs confirmation (7). Moreover, to assess the current epidemiological situation in the whole country, further studies should be performed in the regions not included in this survey.
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